Concepts (66)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Neoplasms | 3 | 2020 | 214 | 1.160 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2015 | 223 | 0.860 |
Why?
|
| Vasospasm, Intracranial | 1 | 2019 | 22 | 0.690 |
Why?
|
| Coronary Vasospasm | 1 | 2019 | 16 | 0.690 |
Why?
|
| Coronary Circulation | 1 | 2019 | 253 | 0.640 |
Why?
|
| Myxoma | 2 | 2017 | 63 | 0.620 |
Why?
|
| Burkitt Lymphoma | 1 | 2020 | 335 | 0.600 |
Why?
|
| Heart Atria | 3 | 2020 | 352 | 0.590 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2016 | 19 | 0.590 |
Why?
|
| Echocardiography | 3 | 2020 | 1182 | 0.560 |
Why?
|
| Antibodies, Antinuclear | 1 | 2015 | 46 | 0.530 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2016 | 167 | 0.500 |
Why?
|
| Coronary Vessels | 1 | 2019 | 665 | 0.480 |
Why?
|
| Aortic Aneurysm | 1 | 2016 | 230 | 0.470 |
Why?
|
| Heart Valve Diseases | 1 | 2015 | 193 | 0.460 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2016 | 303 | 0.350 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2017 | 1237 | 0.320 |
Why?
|
| Thrombosis | 1 | 2014 | 781 | 0.300 |
Why?
|
| Amyloidosis | 1 | 2005 | 176 | 0.220 |
Why?
|
| Heart Failure | 1 | 2015 | 2516 | 0.200 |
Why?
|
| Cardiomyopathies | 1 | 2005 | 610 | 0.170 |
Why?
|
| Cerebral Angiography | 1 | 2019 | 129 | 0.170 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2019 | 216 | 0.160 |
Why?
|
| Electrocardiography | 2 | 2019 | 1145 | 0.150 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 4744 | 0.150 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2017 | 136 | 0.150 |
Why?
|
| Syncope | 1 | 2016 | 64 | 0.140 |
Why?
|
| Coronary Angiography | 1 | 2019 | 598 | 0.140 |
Why?
|
| Myocardium | 2 | 2017 | 1313 | 0.140 |
Why?
|
| Early Diagnosis | 1 | 2016 | 298 | 0.130 |
Why?
|
| Serologic Tests | 1 | 2015 | 137 | 0.130 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2015 | 126 | 0.130 |
Why?
|
| Monitoring, Immunologic | 1 | 2014 | 47 | 0.120 |
Why?
|
| Steroids | 1 | 2015 | 356 | 0.110 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2015 | 323 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 1062 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 7551 | 0.100 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 1375 | 0.080 |
Why?
|
| Biopsy | 1 | 2015 | 3443 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 4892 | 0.070 |
Why?
|
| Female | 6 | 2019 | 141928 | 0.070 |
Why?
|
| Adult | 4 | 2017 | 77950 | 0.070 |
Why?
|
| Humans | 8 | 2020 | 261506 | 0.070 |
Why?
|
| Amyloidosis, Familial | 1 | 2005 | 1 | 0.070 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2005 | 20 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 4320 | 0.060 |
Why?
|
| Amyloid | 1 | 2005 | 97 | 0.060 |
Why?
|
| Biomarkers | 1 | 2015 | 5047 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2015 | 32848 | 0.060 |
Why?
|
| Middle Aged | 2 | 2020 | 86204 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 10035 | 0.040 |
Why?
|
| Photomicrography | 1 | 2017 | 26 | 0.040 |
Why?
|
| Reoperation | 1 | 2017 | 1382 | 0.030 |
Why?
|
| Male | 2 | 2020 | 123000 | 0.020 |
Why?
|
| Thumb | 1 | 1988 | 35 | 0.020 |
Why?
|
| Prognosis | 1 | 2005 | 21713 | 0.020 |
Why?
|
| Bone and Bones | 1 | 1988 | 619 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1988 | 998 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1988 | 2086 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 1988 | 1697 | 0.010 |
Why?
|
| Saudi Arabia | 1 | 1988 | 39 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1988 | 331 | 0.000 |
Why?
|
| Syndrome | 1 | 1988 | 1351 | 0.000 |
Why?
|
| Radiography | 1 | 1988 | 1904 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1988 | 8223 | 0.000 |
Why?
|
| Child | 1 | 1988 | 29154 | 0.000 |
Why?
|